UIC dentine regeneration study targets a protein pathway tied to tooth regrowth
A new dentine regeneration project at the University of Chicago Illinois is taking aim at one of dentistry’s most persistent problems: how to repair decay without turning a living tooth into a passive shell. A $1.2 million award will support work on dentine phosphophoryn, a protein that may help preserve the regenerative capacity of dental pulp cells and guide dentine formation after injury or inflammation.
The biology at the center of the project is autophagy, the cell’s internal recycling system. In healthy tissue, autophagy clears damaged components and repurposes their building blocks, a process that can keep stressed cells alive when they face inflammatory injury. In the dental pulp, where blood vessels, nerves, and stem-cell populations work together to sustain tooth vitality, that kind of cellular housekeeping may be especially important. If autophagy is disrupted, the pulp may lose some of the resilience needed to form new tissue after caries or trauma.
Professor Anna George will study whether dentine phosphophoryn helps protect those cells and maintain their ability to build healthy tooth structure across the life of the tooth. The scientific logic is straightforward: if a protein can support cell survival and keep regenerative pathways intact, it may become part of a future strategy for restoring dentine rather than simply replacing damaged tissue.
The project is not positioned as a cosmetic repair exercise. It is aimed at keeping the tooth biologically active.
From defect removal to a living matrix
Conventional treatment for decay still leans on removal, filling, and reinforcement. Those approaches can stop lesion spread, but they also replace original tissue with synthetic material that does not grow, remodel, or respond like dentine. In practical terms, that means the tooth can be saved structurally while its living biology is reduced.
George’s approach starts from a different premise. Instead of sealing a defect with an inert cap, the work will examine whether proteins can be embedded in a scaffold placed in the dental cavity to stimulate regrow dentine and preserve tooth function. A scaffold-based design matters because it provides a physical matrix for cells to attach to, migrate through, and organize around. If that matrix is biologically active, it could guide regeneration rather than merely occupy space.
The most ambitious part of the concept is not the scaffold itself. It is the hope that the scaffold can help recreate a living environment where the tooth continues to defend itself against cavity progression.
Inflammation and injury are central threats here. Dental pulp tissue does not exist in isolation; once bacterial invasion or mechanical damage reaches deeper layers, the tissue can face oxidative stress, inflammatory signaling, and structural breakdown. A mechanism that sustains autophagy could, in theory, help cells survive long enough to repair the injured area and re-establish a functional dentine barrier. That is the biological bridge between a protein discovery and a plausible restorative therapy.
Human stem cells and animal models will map the pathway
The research plan combines human dental pulp stem cells with animal models to define the molecular pathways governing autophagy and tissue regeneration. This dual approach is important because it allows mechanistic work in human-derived cells while still testing whether those pathways behave similarly in an intact tissue environment. Cellular experiments can reveal how dentine phosphophoryn influences survival signals, recycling mechanisms, and regenerative markers. Animal models can then show whether those effects translate into organized dentine repair inside a living tooth.
The study will also clarify whether dentine phosphophoryn acts directly on the cells responsible for regeneration or whether it influences the surrounding matrix in a broader way. Either answer would matter. Direct stimulation of stem-cell survival would support a targeted biologic therapy, while a matrix-level effect could broaden the protein’s use in restorative materials designed for pulp preservation and dentine repair.
This is where dentistry intersects with regenerative medicine. Rather than treating dentine as a static substance that only needs replacement, the project treats it as a dynamic tissue capable of biologic renewal if the right signals are present.
Why the funding matters for restorative dentistry
The $1.2 million award comes from the National Institute of Dental and Craniofacial Research at the National Institutes of Health and builds on Professor George’s three decades of work at the UIC College of Dentistry. Long-running programs like this tend to matter because regenerative dentistry rarely advances in a single leap. It depends on incremental work that connects protein biology, material science, stem-cell behavior, and tissue repair.
That kind of continuity also gives the field a clearer route from lab observation to bedside application. If a molecule such as dentine phosphophoryn can reliably protect pulp cells from inflammatory injury, then a future therapy could be designed to do more than patch a cavity. It could preserve vitality, slow lesion propagation, and keep the tooth functioning as a living organ rather than a repaired structure.
The clinical implication is obvious, even if the translational path is still early. Regenerating dentine would change the goal of restorative care from replacement to repair.
The unanswered questions are just as concrete. How robust is the autophagy signal in human pulp tissue? Will the protein retain activity in a scaffold inside the oral environment? Can the approach be reproduced consistently enough to matter in everyday dental practice? Those are the barriers that separate a promising biologic concept from a usable therapy, and they will determine whether dentine phosphophoryn becomes part of the next generation of restorative materials or remains a preclinical tool for understanding tooth repair.
For now, the study adds momentum to a field that is moving toward biologically active dentistry, where the objective is not only to fill a defect but to restore the tooth’s own capacity to heal.